237 related articles for article (PubMed ID: 24089559)
21. Increased Gal-3 Mediates Microglia Activation and Neuroinflammation via the TREM2 Signaling Pathway in Prion Infection.
Fan Q; Wu YZ; Jia XX; A R; Liu CM; Zhang WW; Chao ZY; Zhou DH; Wang Y; Chen J; Xiao K; Chen C; Shi Q; Dong XP
ACS Chem Neurosci; 2023 Oct; 14(20):3772-3793. PubMed ID: 37769016
[TBL] [Abstract][Full Text] [Related]
22. Effect of intraventricular infusion of anti-prion protein monoclonal antibodies on disease progression in prion-infected mice.
Song CH; Furuoka H; Kim CL; Ogino M; Suzuki A; Hasebe R; Horiuchi M
J Gen Virol; 2008 Jun; 89(Pt 6):1533-1544. PubMed ID: 18474571
[TBL] [Abstract][Full Text] [Related]
23. Lymphocyte activation gene 3 (Lag3) expression is increased in prion infections but does not modify disease progression.
Liu Y; Sorce S; Nuvolone M; Domange J; Aguzzi A
Sci Rep; 2018 Oct; 8(1):14600. PubMed ID: 30279468
[TBL] [Abstract][Full Text] [Related]
24. Molecular signatures in prion disease: altered death receptor pathways in a mouse model.
Giri RK
J Transl Med; 2024 May; 22(1):503. PubMed ID: 38802941
[TBL] [Abstract][Full Text] [Related]
25. Loss of Perineuronal Net in ME7 Prion Disease.
Franklin SL; Love S; Greene JR; Betmouni S
J Neuropathol Exp Neurol; 2008 Mar; 67(3):189-99. PubMed ID: 18344910
[TBL] [Abstract][Full Text] [Related]
26. Microglia Are Critical in Host Defense against Prion Disease.
Carroll JA; Race B; Williams K; Striebel J; Chesebro B
J Virol; 2018 Aug; 92(15):. PubMed ID: 29769333
[TBL] [Abstract][Full Text] [Related]
27. The NALP3 inflammasome is involved in neurotoxic prion peptide-induced microglial activation.
Shi F; Yang L; Kouadir M; Yang Y; Wang J; Zhou X; Yin X; Zhao D
J Neuroinflammation; 2012 Jul; 9():73. PubMed ID: 22531291
[TBL] [Abstract][Full Text] [Related]
28. Microglial Cx3cr1 knockout reduces prion disease incubation time in mice.
Grizenkova J; Akhtar S; Brandner S; Collinge J; Lloyd SE
BMC Neurosci; 2014 Mar; 15():44. PubMed ID: 24655482
[TBL] [Abstract][Full Text] [Related]
29. THαβ Immunological Pathway as Protective Immune Response against Prion Diseases: An Insight for Prion Infection Therapy.
Tsou A; Chen PJ; Tsai KW; Hu WC; Lu KC
Viruses; 2022 Feb; 14(2):. PubMed ID: 35216001
[TBL] [Abstract][Full Text] [Related]
30. Engulfment of cerebral apoptotic bodies controls the course of prion disease in a mouse strain-dependent manner.
Kranich J; Krautler NJ; Falsig J; Ballmer B; Li S; Hutter G; Schwarz P; Moos R; Julius C; Miele G; Aguzzi A
J Exp Med; 2010 Sep; 207(10):2271-81. PubMed ID: 20837697
[TBL] [Abstract][Full Text] [Related]
31. Protective role of interferon regulatory factor 3-mediated signaling against prion infection.
Ishibashi D; Atarashi R; Fuse T; Nakagaki T; Yamaguchi N; Satoh K; Honda K; Nishida N
J Virol; 2012 May; 86(9):4947-55. PubMed ID: 22379081
[TBL] [Abstract][Full Text] [Related]
32. Remarkable increases of α1-antichymotrypsin in brain tissues of rodents during prion infection.
Chen C; Xu XF; Zhang RQ; Ma Y; Lv Y; Li JL; Shi Q; Xiao K; Sun J; Yang XD; Shi Q; Dong XP
Prion; 2017 Sep; 11(5):338-351. PubMed ID: 28956708
[TBL] [Abstract][Full Text] [Related]
33. TGFbeta1 regulates the inflammatory response during chronic neurodegeneration.
Boche D; Cunningham C; Docagne F; Scott H; Perry VH
Neurobiol Dis; 2006 Jun; 22(3):638-50. PubMed ID: 16510291
[TBL] [Abstract][Full Text] [Related]
34. The role of macrophage scavenger receptor 1 (Msr1) in prion pathogenesis.
Li B; Chen M; Aguzzi A; Zhu C
J Mol Med (Berl); 2021 Jun; 99(6):877-887. PubMed ID: 33758958
[TBL] [Abstract][Full Text] [Related]
35. CD11c is not required by microglia to convey neuroprotection after prion infection.
Carroll JA; Striebel JF; Baune C; Chesebro B; Race B
PLoS One; 2023; 18(11):e0293301. PubMed ID: 37910561
[TBL] [Abstract][Full Text] [Related]
36. The N-terminal, polybasic region of PrP(C) dictates the efficiency of prion propagation by binding to PrP(Sc).
Turnbaugh JA; Unterberger U; Saá P; Massignan T; Fluharty BR; Bowman FP; Miller MB; Supattapone S; Biasini E; Harris DA
J Neurosci; 2012 Jun; 32(26):8817-30. PubMed ID: 22745483
[TBL] [Abstract][Full Text] [Related]
37. A brain aggregate model gives new insights into the pathobiology and treatment of prion diseases.
Bajsarowicz K; Ahn M; Ackerman L; Dearmond BN; Carlson G; DeArmond SJ
J Neuropathol Exp Neurol; 2012 May; 71(5):449-66. PubMed ID: 22507918
[TBL] [Abstract][Full Text] [Related]
38. Microglia in Prion Diseases: Angels or Demons?
Peggion C; Stella R; Lorenzon P; Spisni E; Bertoli A; Massimino ML
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092220
[TBL] [Abstract][Full Text] [Related]
39. Prion protein expression differences in microglia and astroglia influence scrapie-induced neurodegeneration in the retina and brain of transgenic mice.
Kercher L; Favara C; Striebel JF; LaCasse R; Chesebro B
J Virol; 2007 Oct; 81(19):10340-51. PubMed ID: 17652390
[TBL] [Abstract][Full Text] [Related]
40. Neuroinflammation, Microglia, and Cell-Association during Prion Disease.
Carroll JA; Chesebro B
Viruses; 2019 Jan; 11(1):. PubMed ID: 30650564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
